Therapeutic focus
Therapeutic focus
R&D
R&D
Investor relations
Investor relations
About
About
News
News
Contact
Contact
News
14 Mar 2025
Statement on the appointment Dr Renata Crome, Non-Executive Director.
13 Mar 2025
Solvonis acquires Intellectual Property from Awakn Life Sciences, affecting pipeline references.